Meprep maintenance and operation for the medication exposure in pregnancy risk evaluation program (meprep)
Ended Awarded Last action
- Contract number
- HHSF22301001T
- Awardee
-
Harvard Pilgrim Health Care, Inc. UEI NZVVQ8GNVX65
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,293,640
Award facts
- Opportunity
-
- FDARFTOP1164100 Solicitation number
- Contract value 81% obligated
-
- $1,293,639.58 Current, with exercised options
- $1,606,537.86 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wellesley Hills, Wellesley, MA 02481, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $303,632 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $300,038 | |
| Exercise an Option | $308,772 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $381,197 |
About this award
This is a federal contract award to Harvard Pilgrim Health Care Inc., a non-profit healthcare organization, by the Food and Drug Administration (FDA). The contract is a delivery order under the FDA's Scientific Pharmacoepidemiologic Research Program, which is an indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $1,606,537.86 and is for a firm fixed price. The contract supports the FDA's Sentinel Initiative for post-market medical product safety monitoring, including enhancements to the ARIA system and real-world evidence capabilities. This contract does not have a set-aside designation. Harvard Pilgrim has extensive experience conducting large-scale observational studies and clinical trials in partnership with federal health agencies, particularly within the Department of Health and Human Services.
Quick answers
Who was awarded contract HHSF22301001T?
HHSF22301001T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 14, 2016.
How much is contract HHSF22301001T worth?
The government has obligated $1,293,640 on HHSF22301001T. Its potential value, with all options, is $1,606,538.
Is contract HHSF22301001T an order under another contract?
Yes. HHSF22301001T is a delivery order under HHSF223201400042I, an indefinite delivery contract, on FDA Scientific Pharmacoepidemiologic Research Program.
Was contract HHSF22301001T competed?
The extent of competition for HHSF22301001T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award